EUVIMEDEUVIMED entdecken
Crossref

The Full‐Length Genomic Sequence of the HLA ‐B*39:130 Allele

LiXin Li, Wei Tian iD

HLA · 2024

DOI: 10.1111/tan.15769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HLA, 2024. Verfasst von LiXin Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cellular and Molecular Biology, College of Basic Medical Sciences, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Alleles, Introns, Base Sequence. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: Changsha Municipal Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HLA‐B*39:130 differs from HLA‐B*39:01:01:01 at codon 214 (ACA → ATA) and position 355 (T → C) in intron 5.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AllelesIntronsBase SequenceHumansExonsCodonHLA-B39 AntigenHistocompatibility TestingSequence Analysis, DNAPolymorphism, Single Nucleotide

Stichwörter der Autor:innen

HLA‐B*39:130Sanger sequencingcloninglong‐range PCRnovel allele

Substanzen

CodonHLA-B39 Antigen

Autor:innen und Institutionen

  • Laboratory of Cellular and Molecular Biology, College of Basic Medical Sciences, Central South University, Changsha, Hunan, China.
  • Immunogenetics Research Group, Department of Immunology, College of Basic Medical Sciences, Central South University, Changsha, Hunan, China.

ORCID-Profile: Wei Tian

Förderung

  • Changsha Municipal Natural Science Foundation

Zitieren

APA

Li, L., & Tian, W. (2024). The Full‐Length Genomic Sequence of the HLA ‐B*39:130 Allele. HLA. https://doi.org/10.1111/tan.15769

Vancouver

Li L, Tian W. The Full‐Length Genomic Sequence of the HLA ‐B*39:130 Allele. HLA. 2024. doi:10.1111/tan.15769

BibTeX
@article{Li2024,
  author = {Li, LiXin and Tian, Wei},
  title = {The Full‐Length Genomic Sequence of the HLA ‐B*39:130 Allele},
  journal = {HLA},
  year = {2024},
  doi = {10.1111/tan.15769}
}
Kostenlos starten →